clinical data
cancer research
CANCER INTEGRATIVE STUDY
characterized prostate cancer patients
tumour heterogeneity
integration of multiple types of molecular data
understanding of disease mechanisms
leading cause of cancer death
clinicians
Europe
driving molecular alterations
single tumour
Watson technology
actionable clinical statements
therapeutic intervention
implicated mechanisms
Genomic heterogeneity
proposed software framework
challenge
mathematical disease models
therapeutic biomarker panel
predictive computational technology
major therapeutic advances
individual patients
treatment recommendations
exploitation of genomic
over-treatment
target subsets of aggressive tumour cells
multiple competing subclones
prospective cohorts
EVALUATION Despite
drug screenings
great promise
metastatic tumours
high-throughput technologies
future development
cell lines
industrial partners
proof of concept
generation cognitive computer
PERSONALIZED ENGINE
optimized strategies
therapies
researchers
dissemination
graphical interface
IBM
biomedical industries
intuitive tools
share
approach
translational objective
prognosis
therapy